NAMPT and fetal growth restriction: In our study, we demonstrated for the first time the expression and immunolocalization of visfatin in human trophoblast JEG-3 and BeWo cells as well as in terminal placentas from normal pregnancies and pathologies such as IUGR, PE, and GDM.